{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-017516","form_type":"8-K","ticker":"RKDA","cik":"0001469443","company_name":"Arcadia Biosciences, Inc.","filed_at":"2022-08-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.853029+00:00","generated_at":"2026-06-23T23:26:34.664072+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Arcadia Biosciences raises ~$5M via registered direct offering of common stock and warrants","bullets":["Sold 4,722,506 shares at $1.05876 per share plus pre-funded warrants to an institutional investor.","Issued investment options for 4,722,506 shares at $0.93376, exercisable immediately for 5 years.","H.C. Wainwright earned a 6% cash fee (est. $300K) plus warrants for 236,125 shares at $1.3235.","Closing occurred August 16, 2022; offering priced at-the-market under Nasdaq rules."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-017516","json":"https://secwatch.observer/filing/0000950170-22-017516.json","markdown":"https://secwatch.observer/filing/0000950170-22-017516.md","text":"https://secwatch.observer/filing/0000950170-22-017516.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1469443/000095017022017516/0000950170-22-017516-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1469443/000095017022017516/rkda-20220812.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T23:26:34.664072+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}